Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mathé

Showing results (201-210 of 550) with videos related to

Pageof 55
Sort By:
Minerva Medica|October 27, 1985
[The ethics of therapeutic experimentation are a part of scientific integrity]P Arpaillange, S Dion, G Mathé
Semaine Des Hopitaux. Therapeutique|January 1, 1975
[Phase II therapeutic trial (screening) of ifosfamide in hematosarcomas and solid tumors]B Clavel, G Mathé, M Hayat
Drugs Under Experimental and Clinical Research|January 1, 1986
Clinical trials of the treatment of minimal residual tumoursG Mathé, P Reizenstein, M Eriguchi
Semaine Des Hopitaux. Therapeutique|March 1, 1976
[Aseptic hospital units]L Schwarzenberg, L Jacques, G Mathé
Annales De Medecine Interne|May 1, 1973
[Trials of active immunotherapy in the treatment of acute lymphoid leukemia: influence of diverse factors on the results]G Mathé, P Pouillart, L Schwarzenberg
Supplement ... to the Journal Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Abnormal in vitro differentiation of clonogenic B-cells in common acute lymphoblastic leukemia in complete remission. A marker for minimal residual disease?J Bréard, G Mathé, R Consolini
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|March 1, 1989
Can neo-adjuvant chemotherapy prevent residual tumors?C Bourut, E Chenu, G Mathé
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|March 1, 1989
Adjuvant treatment of minimal residual tumors. A comparison of chemotherapy and immunotherapyG Mathé, P Reizenstein, M Eriguchi
Experientia|April 15, 1971
Active immunotherapy of mouse RC 19 and E female K1 leukaemias applied after the intravenous transplantation of the tumour cellsG Mathé, P Pouillart, F Lapeyraque
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Notes on the cardiotoxicity of platinum complexes (except 1-OHP) in ultrastructural studyA Anjo, D Dantchev, G Mathé
Pageof 55

Showing results (201-210 of 550) with videos related to

Sort By:
Pageof 55
Minerva Medica|October 27, 1985
[The ethics of therapeutic experimentation are a part of scientific integrity]P Arpaillange, S Dion, G Mathé
Semaine Des Hopitaux. Therapeutique|January 1, 1975
[Phase II therapeutic trial (screening) of ifosfamide in hematosarcomas and solid tumors]B Clavel, G Mathé, M Hayat
Drugs Under Experimental and Clinical Research|January 1, 1986
Clinical trials of the treatment of minimal residual tumoursG Mathé, P Reizenstein, M Eriguchi
Semaine Des Hopitaux. Therapeutique|March 1, 1976
[Aseptic hospital units]L Schwarzenberg, L Jacques, G Mathé
Annales De Medecine Interne|May 1, 1973
[Trials of active immunotherapy in the treatment of acute lymphoid leukemia: influence of diverse factors on the results]G Mathé, P Pouillart, L Schwarzenberg
Supplement ... to the Journal Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Abnormal in vitro differentiation of clonogenic B-cells in common acute lymphoblastic leukemia in complete remission. A marker for minimal residual disease?J Bréard, G Mathé, R Consolini
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|March 1, 1989
Can neo-adjuvant chemotherapy prevent residual tumors?C Bourut, E Chenu, G Mathé
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|March 1, 1989
Adjuvant treatment of minimal residual tumors. A comparison of chemotherapy and immunotherapyG Mathé, P Reizenstein, M Eriguchi
Experientia|April 15, 1971
Active immunotherapy of mouse RC 19 and E female K1 leukaemias applied after the intravenous transplantation of the tumour cellsG Mathé, P Pouillart, F Lapeyraque
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Notes on the cardiotoxicity of platinum complexes (except 1-OHP) in ultrastructural studyA Anjo, D Dantchev, G Mathé
Pageof 55